Major varicella vaccine manufacturers include Merck & Co./MSD and GSK, with additional regional manufacturers serving markets in Asia and other regions. Product authorization and availability differ by country.
Answer
Varicella vaccine is the clinical term for the vaccine used to prevent chickenpox. Merck/MSD and GSK are the most internationally recognized manufacturers, although several regional biological manufacturers also produce varicella vaccines for specific domestic and export markets.
Merck manufactures Varivax, a single-antigen live attenuated varicella vaccine, and ProQuad, which combines measles, mumps, rubella, and varicella antigens. In the United States, Varivax remains the single-antigen product, and ProQuad is an MMRV option for eligible children. GSK manufactures Varilrix, a live attenuated varicella vaccine registered in numerous countries outside the United States.
Regional manufacturers may offer Oka-strain or locally developed products, but their regulatory status, clinical evidence, production standards, and eligible age groups must be evaluated independently. A national license does not automatically make a product authorized in other jurisdictions.
Institutional purchasers should verify:
• National marketing authorization
• WHO prequalification or applicable procurement eligibility
• Single-antigen or combination formulation
• Approved age range and dosing schedule
• Cold-chain and reconstitution requirements
• Batch-release and pharmacovigilance arrangements
• Manufacturer and local registration-holder responsibilities
The difference from a consumer-oriented “chickenpox vaccine” search is that varicella procurement requires exact regulatory and technical specifications. The current package insert and national immunization program should determine product selection rather than manufacturer reputation alone.

Trust Our Expert Answers?
Strengthen Your Product Portfolio
AdvaCare Pharma provides internationally distributed pharmaceutical and healthcare products supported by market-specific registration and supply-chain capabilities.

